BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations
 


Press Release

Tacoma/Valley Radiation Oncology Centers Provide New Cancer Treatment in Pacific Northwest with Acquisition of BSD-500 Hyperthermia System

TACOMA, WASHINGTON, April 23, 2009—BSD Medical Corporation (NASDAQ:BSDM) is pleased to announce that the Tacoma/Valley Radiation Oncology Centers in Tacoma, Washington have become the first oncology centers in the Pacific Northwest to acquire the BSD-500 Hyperthermia System. This placement emphasizes the ever growing use of hyperthermia therapy throughout the United States. The addition of the system significantly adds to the multidisciplinary arsenal of cancer treatment options Tacoma/Valley Radiation Oncology Centers provide to the Puget Sound region. “We are pleased to have this modality to offer our patients”, said Randy Sorum, MD of Tacoma/Valley Radiation Oncology Center.

About Tacoma/Valley Radiation Oncology Center

Celebrating over 30 years of operation, Tacoma/Valley Radiation Oncology Center (TVROC) has been recognized as a major provider of radiation oncology services in the Puget Sound region. TVROC offers comprehensive care, advanced technology and innovative treatments to cancer patients.

About BSD Medical Corporation

BSD Medical Corp. is a leading developer of systems used to deliver precision-focused microwave/RF energy to diseased sites in the body, including cancer. Its treatments are used to kill cancer directly and increase the effectiveness of companion radiation treatments for certain tumors. For further information visit BSD Medical's website at www.BSDMedical.com.

###

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.